Connect with us

BIOTECH

Cure Pharmaceutical Holding Corp (OTCMKTS:CURR) Adds New Top Management Member

Published

on

Cure Pharmaceutical Holding Corp (OTCMKTS:CURR) recently added Dr. Vered Gigi, as the new Vice President of Strategy and Business Development. Dr. Gigi will manage the company’s strategies and support it to deliver sustainable development and diversified revenue. Jessica Rousset, Chief Operating Officer of CURE stated that the appointment comes at the time when the company is planning to focus on both the established and new strategic partnerships to drive the growth.

Dr. Gigi brings on board expansive relationships, knowledge, and experience, having worked for several companies in the pharma industry. Before joining CURE, Dr. Gigi was working as project leader at The Boston Consulting Group. She has developed strong links with global biopharma and medtech firms focusing specifically on the corporate and network strategy, operations, and marketing.

She has a Bachelor’s Degree and a Master’s Degree in Immunotherapy and Stem Cell from Tel-Aviv University in Israel. She also earned her PhD in Immunology from the University of Pennsylvania specializing on the DNA repair methods and genome sequencing.

During her inauguration, Dr. Gigi stated that she is delighted to join the CURE team especially with the presence of the technology that offers a clear path for advanced medications for the betterment of patients. She promised to work with the team to enhance the efficacy and safety of both new and existing drugs.

CURE recently announced the launch of its new brand initiative, to support the patient needs and requirements to improve the delivery of medication. The company stated that the new branding offers them with opportunities to increase the awareness about the challenges the patients experience when using traditional drug delivery methods, including the pills and injections and highlight concrete solutions.

CURE also restated its mission statement to be ‘We improve people’s lives by redefining how medicines are delivered and experienced’ which underlines its commitment to better the lives of patients. Furthermore, company is launching a new logo, which integrates the initial ‘C’ in a circular motion, representing the company’s 360-degree commitment to the patient’s vitality.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.